<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02698020</url>
  </required_header>
  <id_info>
    <org_study_id>ANOXneo</org_study_id>
    <nct_id>NCT02698020</nct_id>
  </id_info>
  <brief_title>Optimized Oxygen Delivery During General Anesthesia in Newborn Infants</brief_title>
  <acronym>ANOXneo</acronym>
  <official_title>Oxygen Delivery During General Anesthesia in Newborn Infants: An Open Randomized Controlled Trial of Two Levels of Inspired Oxygen.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An open randomized control trial investigating the delivery of two levels of inspired oxygen
      to newborn infants during general anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible infants are infants of less than 44 weeks postconceptional age and without pulmonary
      disease or demand for supplemental oxygen or assisted ventilation. Control subjects receive
      current standard of care (anesthesia induction/pre-oxygenation with 80%, maintenance of
      anesthesia with 40%, and recovery with 80% inspired oxygen). Intervention subjects are
      maintained on room air throughout the procedure and supplemental oxygen added only if
      necessary according to the pre-specified oxygen saturation target. Subjects are monitored
      according to clinical protocols AND with cerebral oximetry (NIRS), transcutaneous measurement
      of partial pressure of oxygen (pO2), and blood-gas analyses. Blood and urine samples are
      collected for later analysis of markers for oxidative stress.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Transcutaneous and blood-gas pO2</measure>
    <time_frame>30 min</time_frame>
    <description>Area under curve (AUC) and absolute values of pO2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cerebral Oximetry</measure>
    <time_frame>30 min</time_frame>
    <description>AUC of O2 saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atelectasis</measure>
    <time_frame>30 min</time_frame>
    <description>Reduced lung compliance as a measure of atelectasis formation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isoprostane</measure>
    <time_frame>4 h</time_frame>
    <description>Level of isoprostanes in blood and urine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Oxygen Toxicity</condition>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>High level of supplemental inspired oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Room-air</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supplemental oxygen only provided if oxygen saturation below target</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Room-air</intervention_name>
    <description>Provision of room-air</description>
    <arm_group_label>Room-air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        1. Newborn less than 44 weeks postconceptional age

          2. No pulmonary disease, no oxygen requirement, or assisted ventilation

          3. No genetic syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johan Agren, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Women's and Children's Health, Uppsala University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johan Agren, MD, PhD</last_name>
    <phone>+46703866966</phone>
    <email>johan.agren@kbh.uu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Victoria Karlsson, RN</last_name>
    <email>victoria.karlsson@kbh.uu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uppsala University Hospital, Pediatric anesthesia Unit</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan Agren, MD, PhD</last_name>
      <phone>+46703866966</phone>
      <email>johan.agren@kbh.uu.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2016</study_first_submitted>
  <study_first_submitted_qc>February 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2016</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Newborn</keyword>
  <keyword>Anesthesia</keyword>
  <keyword>Oxygen</keyword>
  <keyword>Hyperoxia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

